Tata Consultancy Services

Size: px
Start display at page:

Download "Tata Consultancy Services"

Transcription

1 4QFY15 Result Update Institutional Equities Tata Consultancy Services Reuters: TCS.BO; Bloomberg: TCS IN 17 April 215 Standalone P/E to crunch; P/E premium will depend on peers Tata Consultancy Services (TCS) 4QFY15 numbers were disappointing. The biggest negative surprise was on the revenue front where on a constant currency (CC) basis revenue growth at 1.6% in USD terms came in lower than our and consensus expectation as well as the mid quarter guidance of ~2.5%. TCS has indicated an aspiration to grow above NASSCOM s growth estimate for FY16 of 12-14%. It does not want to call it guidance. This aspiration looks fairly ambitious considering FY16 looks challenging for a few verticals - Oil & gas, Insurance and Telecom (as per TCS). It started FY15 with no such headwinds and was able to deliver CC organic growth of 15%. Unless these sectors take a turn for the better, we think achieving its aspiration will be a tall order. The big positive surprise in INR EBIT margin (QoQ up from 27% to 27.2% vs our expectation of decline to 26.5%) was driven entirely by lower SGA (9bps decline). While some of the decline in SGA is likely currency related we also believe that there has been a cut back in investments not a positive sign for growth going ahead. We believe SGA would be pared going ahead as TCS would want to calibrate it depending on head room that is available. We don t think there will be much headroom in FY16 considering the steep salary hike given to offshore and onsite employees (8% and 3% on an average respectively). The net hiring number (~1) is a multi- year low and is worrisome in the context of its (1) very high utilization number (~85% excl trainees) (2) its multi year high attrition of 14.9% in 4Q and (3) its aspiration to grow above Nasscom growth target of 12-14% for FY16. P/E premium to industry to be determined by peer s performance: With what has been clearly a disappointing set of numbers, we expect the standalone P/E multiple of TCS company to contract further from current levels and move towards our target P/E multiple of of 18.1x. TCS s P/E premium to its peers has narrowed to 1%-15% versus the 3%-35% that it used to trade in its best phase in 214. We think this lower premium reflects the market s perception that the growth rate gap between peers and TCS will narrow sharply in FY16 and beyond. Where the discount will settle at (we still think it will be a discount as we currently think that TCS will continue to be one of the fastest growing companies in the foreseeable future among the India Tier-1 set) will entirely depend on what peers s outlook on growth for FY16 is and what they deliver in terms of March 215 quarter numbers.. View on Stock and estimates: We maintain Sell on TCS with a revised Target price of Rs2,325.There have been some modest revisions to our EPS estimates. Our negative thesis on the sector and TCS is reflected in our report Structural and Cyclical Speed Breakers ahead which is available here (Information Technology Sector). SELL Sector: Information Technology CMP: Rs2,574 Target Price: Rs2,325 Downside: 1% Girish Pai girish.pai@nirmalbang.com Key Data Current Shares O/S (mn) 1,958.7 Mkt Cap (Rsbn/US$bn) 5,59/ Wk H / L (Rs) 2,84/1,969 Daily Vol. (3M NSE Avg.) 1,323,96 Price Performance 1 M 6 M 1 Yr TCS.4 (.9) 26.8 Nifty Index (.2) Source: Bloomberg Y/E March (Rsmn) 4QFY14 3QFY15 4QFY15 YoY QoQ Net sales 215, ,11 242, (1.1) Software expenses 114,64 135, , % of sales Operating expenses 38,61 43,611 41, 7.7 (6.) % of sales (73) (87) EBIT 62,81 66,242 65, (.5) EBIT Margin (193)bps 18bp Other Income 6,99 6,295 11, PBT 69,8 72,537 77, Provision for tax 16,313 17,453 17, Effective tax rate Minority share in profit / loss (25.2) (39.5) PAT (reported) 52,967 54,441 59, NPM (19)bps 216bps Please refer to the disclaimer towards the end of the document.

2 Exhibit 1: Key financials Y/E March (Rsmn) FY14 FY15 FY16E FY17E FY18E Revenue ,52 1,184 1,316 YoY EBIT EBIT Adj. PAT YoY FDEPS (Rs) RoE RoCE ROIC P/E (x) P/B (x) Exhibit 2: Change in estimates New Old Change FY16E FY17E FY16E FY17E FY16E FY17E INR/USD US$ Revenue 17,175 18,788 17,443 19,81 (1.5) (1.5) Revenue (Rsmn) 1,52 1,184 1,64 1,22 (1.1) (1.5) EBIT (Rsmn) (.9) (2.7) PAT (Rsmn) (.2) (.9) EPS (Rs) (.) (1.) Analyst call Highlights The CC revenue growth of 1.6% qoq can be broken down into 3 components volume growth of 1.42%, positive price realization impact of.79% and negative offshore shift impact of.6%. In FY15, the revenues grew 17% in cc terms and 15.7% in INR terms YoY. The entire 17% revenue growth was driven by volumes. The company has rolled out a new employee cash reward program as a bonus payout to all its employees for completing its 1 years since the launch of IPO in 25. It is a one-time payout of Rs.26.28bn. Among industry verticals, it faced headwinds in 3 segments Energy & Utilities, Telecom, and Insurance (exclusively due to Diligenta). Revenues de-grew by 6.2% qoq in Telecom and 4.7% in Energy & Utilities. Insurance segment is facing headwinds largely due to Diligenta. Excluding Diligenta, Insurance segment has grown yoy, whereas, Diligenta has de-grown. Turn around in Diligenta is at least 2-3 quarters away according to the company. Apart from these 3 headwinds, all the other segments have shown a robust performance. TCS expects BFS business to do in-line or higher than company performance. TCS reported a net employee addition of 131 during the quarter, while the gross addition was employees, taking the total employee count to For FY16, the company is expecting to hire 6 employees out of which 35 would be campus hires. TCS reported attrition of 14.9%, which is the highest in the last 1 years. According to TCS, this is largely an industry phenomenon as there are a large number of growth opportunities and is indicative of the fact that there is strong demand for IT Services. But the management is focused to reduce this number. Among geographies, all regions have been able to register growth (qoq), except India which was almost flattish for the quarter. UK has registered a strong growth of 2.4%, despite being a headwind from Diligenta. Continental Europe has grown by more than 25% yoy. Among the service lines, Growth is led by infrastructure, followed by assurance, enterprise solutions and BPS. Digital and cloud has done extremely well. The company has crossed the $125mn revenue run-rate in some of its cloud based platforms.. TCS is launching a new Artificial Intelligence based Platform. It is a neuroscience based platform which will help in automating services. It is a self learning platform which will learn and streamline its processes with time. It will be mostly used in IT Services, BPS and IMS. According to the company, all the 5 pilot projects have been successful and well received by a number of clients. The company expects that there will be a slight uptick in the client budget for IT services expenditure in FY16 as compared to FY15 and the theme will be led increase in digital spending by the clients. 2 Tata Consultancy Services

3 Apr-12 1QFY14 Jun-12 Aug-12 2QFY14 Oct-12 Dec-12 Feb-13 3QFY14 Apr-13 Jun-13 4QFY14 Aug-13 Oct-13 Dec-13 1QFY15 Feb-14 Apr-14 2QFY15 Jun-14 Aug-14 3QFY15 Oct-14 Dec-14 Feb-15 4QFY15 Apr-15 Apr-12 Jun-12 1QFY14 Aug-12 Oct-12 2QFY14 Dec-12 Institutional Equities Feb-13 Apr-13 3QFY14 Jun-13 Aug-13 4QFY14 Oct-13 Dec-13 1QFY15 Feb-14 Apr-14 Jun-14 2QFY15 Aug-14 Oct-14 3QFY15 Dec-14 Feb-15 4QFY15 Apr-15 Exhibit 3: TCS three year P/E chart Why are we negative on TCS We expect slower US dollar (USD) revenue CAGR of 1% over FY15E-FY18E versus historical fiveyear/three-year (ending FY15) CAGR of 19.5%/15.7%, respectively and therefore believe that it should trade at lower multiples than it is doing currently on FY17 EPS. Our FY17 revenue/ebit/eps estimates are 5.3%/13.7%/1.2% below Bloomberg consensus estimates, respectively. Slower revenue growth for TCS largely stems from our concerns about growth detailed in the sector analysis (please read the sector report whose link is given in the first page of this note). Specifically with respect to TCS we are concerned about (1) its large size (among the largest volume players in the global IT services business currently) (2) its large exposure to the BFSI sector, which we believe will be weak in terms of growth over the forecasted period due to slower IT spend by its customers (3) its large exposure to legacy businesses which are likely to witness value/volume compression in an era of automation/frameworks and (4) lower market share gains because of convergence of capabilities/strategies of different players in the Tier-1 India player set. TCS has lost some P/E premium it used to command as the market perceived that the growth rate gap it enjoyed in FY14 and FY15 versus peers is likely to contract over FY15E-FY18E. Will still likely grow ahead of industry: Despite slower growth compared to its past, TCS will likely deliver industry leading revenue growth and margins in the foreseeable future because of its well-rounded business mix among Tier-1 set of peers (defined as India-listed companies with >US$5bn in revenue). It has the broadest range of capabilities - service line, vertical and delivery - in the peer set and these will still lead to consistent, broad-based growth across several quarters. TCS has invested in new growth drivers, which we believe will deliver over FY15E-FY18E. As investments start paying off, we believe it will maintain EBIT margin of around 25% and RoIC of > 5% over FY15E-FY18E. TCS has been good at both account hunting and mining with an impressive number of relationships not only added, but also scaled up. This has been possible because of the breadth of its capabilities and strong execution. Therefore while we believe the stock is overpriced, we have TCS as the P/E benchmark for the sector and have accorded it the highest Target P/E of 18.1x. All other companies have target P/Es that are at a discount to that of TCS. (Rs) 3, 2,5 (x) , 1, , Price P/E 3-yr mean 1sd -1sd Source: Bloomberg, Nirmal Bang Institutional Equities Research Exhibit 4: The dollar revenue growth has fallen steeply due to both growth slowdown and cross currency impact (1) (.8) (2) USD revenue growth (YoY) USD revenue growth (QoQ) 3 Tata Consultancy Services

4 1QFY14 2QFY14 3QFY14 4QFY13 4QFY14 1QFY14 Institutional Equities 1QFY15 2QFY14 3QFY14 2QFY15 4QFY14 3QFY15 1QFY15 2QFY15 4QFY15 3QFY15 4QFY15 Exhibit 5: Low SGA has led to EBIT margins come in higher than 27% despite a gross margin hit QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 Gross margin SG&A as % of sales EBIT margin Exhibit 6: Net employee addition 12, 1, 9,751 8,326 8, 7,664 6, 5,463 4,967 4,868 4, 2, 1,39 1,31 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 Exhibit 7: IMS continues to be the main driver of growth amongst service lines (INR terms) QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 IMS growth (YoY) BPM growth (YoY) ADM growth (YoY) Exhibit 9: Attrition is at a historic high Exhibit 8: Utilization is running high Utilization (excluding trainees) Attrition Source: Companies, Nirmal Bang Institutional Equities Research 4 Tata Consultancy Services

5 Exhibit 1: Key metrics 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 Revenue (US$mn) 2,728 2,853 2,948 3,4 3,165 3,337 3,438 3,53 3,694 3,929 3,931 3,9 EBIT (US$mn) ,7 1,23 1, ,55 1,63 1,61 PAT (US$mn) P&L (Rsmn) Revenue 148, ,28 16, ,31 179,871 29, ,94 215, ,11 238, ,11 242,198 EBITDA 4,897 41,789 43,89 43,584 48,627 63,295 63,347 62,81 58,149 63,942 66,242 65,911 PAT 32,748 35,123 35,516 34,97 39,866 46,539 51,797 52,967 5,578 52,884 54,441 59,59 Vertical mix BFSI Manufacturing Telecom Life sciences Retail Energy and utility Horizontal mix Application development & maint Business Intelligence Product engineering services Enterprise solutions Infrastructure management Business process outsourcing Delivery Offshore Onsite Project type T&M Fixed price Staff utilisation (including trainees) Client concentration Top client Top 5 clients Top 1 clients Number of clients US$1mn US$5mn Employees 243, ,76 263, , , ,25 29,713 3,464 35, , , ,656 Attrition Tata Consultancy Services

6 Financials Exhibit 11: Income statement Y/E March (Rsbn) FY14 FY15 FY16E FY17E FY18E Average INR/USD Net sales (US$mn) 13,443 15,454 17,175 18,788 2,559 -Growth Net sales ,52 1,184 1,316 -Growth Direct costs Gross margin % of sales SG& A % of sales EBIT % of sales Other income (net) PBT PBT margin Provision for tax Effective tax rate Minority interest Net profit Growth Net profit margin Exhibit 13: Balance sheet Y/E March (Rsbn) FY14 FY15 FY16E FY17E FY18E Equity capital Reserves & surplus Net worth Minority interest Other liabilities Total loans Total liabilities Goodwill Net block (incl. CWIP) Investments Deferred tax asset - net Other non-current assets Other current assets Debtors Cash & bank balance Bank deposits Total current assets Total current liabilities Net current assets Total assets Exhibit 12: Cash flow Y/E March (Rsbn) FY14 FY15 FY16E FY17E FY18E EBIT (Inc.)/dec. in working capital (95) (2) (77) (79) (81) Cash flow from operations Other income (17) (13) (3) (37) (39) Depreciation & amortisation Financial expenses Tax paid (61) (67) (7) (77) (84) Dividends paid (55) (17) (133) (145) (165) Net cash from operations 25 3 (21) (26) (28) Capital expenditure (22) (12) (18) (17) (17) Net cash after capex 3 (9) (39) (44) (45) Inc./(dec.) in debt () (Inc.)/dec. in investments (14) Equity issue/(buyback) Cash from financial activities (15) Others 7 (5) Opening cash Closing cash Change in cash (4) 4 6 () Exhibit 14: Key ratios Y/E March FY14 FY15 FY16E FY17E FY18E EPS FDEPS Dividend per share Book value Dividend payout ratio (excl. DT) Return ratios RoE RoCE RoIC Turnover ratios Asset turnover ratio Debtor days (incl. unbilled rev.) Working capital cycle days Valuation ratios (x) PER P/BV EV/EBTDA EV/sales M-cap/sales Tata Consultancy Services

7 Rating track Date Rating Market price (Rs) Target price (Rs) 13 April 215 Sell 2,619 2, April 215 Sell 2,574 2,325 7 Tata Consultancy Services

8 Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is published by Nirmal Bang s Institutional Equities Research desk. Nirmal Bang has other business units with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. This report is for the personal information of the authorised recipient and is not for public distribution. This should not be reproduced or redistributed to any other person or in any form. This report is for the general information for the clients of Nirmal Bang Equities Pvt. Ltd., a division of Nirmal Bang, and should not be construed as an offer or solicitation of an offer to buy/sell any securities. We have exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but do not guarantee its accuracy or completeness. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Nirmal Bang or any persons connected with it do not accept any liability arising from the use of this document or the information contained therein. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information. Nirmal Bang or any of its connected persons including its directors or subsidiaries or associates or employees or agents shall not be in any way responsible for any loss or damage that may arise to any person/s from any inadvertent error in the information contained, views and opinions expressed in this publication. Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited. NBEPL is in the process of making an application with SEBI for registering as a Research Entity in terms of SEBI (Research Analyst) Regulations, 214. NBEPL or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. NBEPL or its associates/analyst has not received any compensation from the company covered by Analyst during the past twelve months. NBEPL /analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market-making activity of the company covered by Analyst. The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com , Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com /811, Michael Pillai Dealing Desk michael.pillai@nirmalbang.com /813, Umesh Bharadia Dealing Desk umesh.bharadia@nirmalbang.com Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 31/32, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-413. Board No. : /1; Fax. : Tata Consultancy Services

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE 2QFY18 Result Update Institutional Equities Swaraj Engines 13 November 2017 Reuters: SWAR.BO; Bloomberg: SWE IN Strong Realisation Drives Earnings Growth Swaraj Engines (SEL) 2QFY18 earnings were 5% above

More information

Institutional Equities

Institutional Equities 3QFY15 Result Update Institutional Equities GlaxoSmithKline Consumer Healthcare Reuters: GLSM.BO; Bloomberg: SKB IN 4 February 2015 Price Hike Leads To Sales Growth Glaxo SmithKline Consumer Healthcare

More information

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy 4QFY16 Result Update Institutional Equities Timken India 23 May 2016 Reuters: TMKN.BO; Bloomberg: TIMK IN Margin Expansion Leads To Huge Growth In Profit; Retain Buy Timken India (TIL), the leading manufacturer

More information

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely 4QFY15 Result Update Crompton Greaves 29 May 2015 Reuters: CROM.BO; Bloomberg: CRG IN Overseas Losses Continue; More Business Exits Likely The 4QFY15 performance of Crompton Greaves (CGL) was below expectation

More information

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy 2QFY18 Result Update Power Mech Projects 23 November 217 Reuters: POMP.BO; Bloomberg: POWM IN Strong Business Scalability Likely; Retain Buy Power Mech Projects (PMPL) posted 2QFY18 consolidated revenues

More information

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport 3QCY17 Result Update Institutional Equities Crisil 18 October 2017 Reuters: CRSL.BO; Bloomberg: CRISIL IN Weak SME Rating Revenues & Currency Movement Play Spoilsport Crisil s 3QCY17 performance was below

More information

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update 3QFY15 Result Update Institutional Equities Bajaj Electricals 13 February 2015 Reuters: BJEL.BO; Bloomberg: BJE IN Final Phase Of Transition Pain; Retain Buy Bajaj Electricals (BJE) posted 3QFY15 revenue

More information

Institutional Equities

Institutional Equities 2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of

More information

Institutional Equities

Institutional Equities Management Meet Update Institutional Equities Kaya Reuters: KAYA.NS; Bloomberg: KAYA IN We interacted with the management of Kaya at an investor conference held by us recently. Following are the key takeaways:

More information

Punjab National Bank

Punjab National Bank 4QFY15 Result Update Institutional Equities Punjab National Bank 11 May 2015 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Disappointment Continues Punjab National Bank (PNB) posted dismal 4QFY15 performance,

More information

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514 3QFY15 Result Update Institutional Equities Cadila Healthcare 11 February 2015 Reuters: CADI.BO; Bloomberg: CDH IN Stable Performance Cadila Healthcare s (CHL) 3QFY15 earnings were in line with our expectations

More information

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated Management Meet Update Institutional Equities Persistent Systems 22 June 2016 Reuters: PERS.BO; Bloomberg: PSYS IN Watson IOT Bet Risk/Reward More Muted Than Anticipated We had a meeting with Persistent

More information

3,746 2,551 3, NIM

3,746 2,551 3, NIM 4QFY17 Result Update Institutional Equities Capital First 11 May 2017 Reuters: CAPF.BO; Bloomberg: CAFL IN Net Interest Income Up, But Offset By Elevated Credit Costs Although the net interest income or

More information

9,251 7,812 8, NIM

9,251 7,812 8, NIM 4QFY15 Result Update Institutional Equities IndusInd Bank 17 April 2015 Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Robust Performance IndusInd Bank s 4QFY15 profit beat our estimate by 12%. Its bottom-line

More information

Punjab National Bank

Punjab National Bank 1QFY16 Result Update Institutional Equities Punjab National Bank 29 July 2015 Reuters: PNB.BO; Bloomberg: PNB IN Some Respite On Asset Quality Front Punjab National Bank (PNB) reported moderate 1QFY16

More information

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities CARE Ratings 17 November 217 Reuters: CREI.BO; Bloomberg: CARE IN Mixed Performance CARE Ratings (CARE) reported an increase of 12.3% in revenues for 2QFY18

More information

9,807 8,007 9, NIM

9,807 8,007 9, NIM 1QFY16 Result Update Institutional Equities IndusInd Bank Reuters: INBK.BO; Bloomberg: IIB IN Yet Another Stellar Performance IndusInd Bank s 1QFY16 profit beat our estimate by 4%. Its bottom-line grew

More information

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017 1QFY18 Result Update Institutional Equities Muthoot Finance 10 August 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Continues To Glitter Strong profitability numbers of Muthoot Finance (MFL)

More information

93,707 77,814 90, NIM

93,707 77,814 90, NIM 1QFY18 Result Update Institutional Equities HDFC Bank Reuters: HDBK.BO; Bloomberg: HDFCB IN Higher Fee Income Offsets Higher Provisioning HDFC Bank s net interest income or NII grew 20% in 1QFY18 driven

More information

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY 2QFY18 Result Update Institutional Equities Muthoot Finance 10 November 2017 Reuters: MUTT.BO; Bloomberg: MUTH IN Gold Loan Business Really Glitters Strong profitability numbers of Muthoot Finance (MFL)

More information

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance 2QFY19 Result Update Gillette India 13 February 2019 Reuters: GILE.NS; Bloomberg: GILL IN Marketing Investments Mask Improved Top-line Performance Gillette India s (GILL) 2QFY19 operating and net earnings

More information

EBITDA 5,019 4,211 5, EBITDA

EBITDA 5,019 4,211 5, EBITDA Result Update Institutional Equities Dalmia Bharat Reuters: DALA.BO; Bloomberg: DBEL IN Outperformance Likely To Continue Dalmia Bharat (DBL) reported a good set of numbers for, given the challenging environment

More information

Colgate-Palmolive (India)

Colgate-Palmolive (India) Result Update Colgate-Palmolive (India) 27 July 218 Reuters: COLG.BO; Bloomberg: CLGT IN Tough Times Continue Colgate-Palmolive (India) or CLGT reported a mixed earnings performance in. Volume and revenue

More information

Jamna Auto Industries

Jamna Auto Industries 2QFY19 Result Update Institutional Equities Jamna Auto Industries Reuters: JMNA.NS; Bloomberg: JMNA IN Performance Below Expectations; Retain Buy Due To Strong Outlook Jamna Auto s 2QFY19 earnings were

More information

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL

Tech Mahindra. Institutional Equities. Company Interaction & Event Update SELL Company Interaction & Event Update Institutional Equities Tech Mahindra 7 March 2017 Reuters: TEML.BO; Bloomberg: TECHM IN Broadly Maintain Our Outlook On Organic Growth And Margins We interacted with

More information

Institutional Equities

Institutional Equities Company Update Institutional Equities Dr. Reddy s Laboratories 5 September 2017 Reuters: REDY.BO; Bloomberg: DRRD IN Suboxone Generic Opportunity To Be Lucrative, Can Sustain For Longer Time The district

More information

E&P To Stay Strong; Consumer Segment To Revive

E&P To Stay Strong; Consumer Segment To Revive Management Meet Update Institutional Equities Bajaj Electricals 30 August 2017 Reuters: BJEL.BO; Bloomberg: BJE IN E&P To Stay Strong; Consumer Segment To Revive We had a meeting with the management of

More information

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Bata India. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Institutional Equities Bata India 23 July 2018 Reuters: BATA.BO; Bloomberg: BATA IN Strong Margin Improvement To Drive Consensus EPS Upgrade Bata India s (BIL) YoY net sales growth

More information

Punjab National Bank

Punjab National Bank 1QFY18 Result Update Institutional Equities Punjab National Bank 3 August 2017 Reuters: PNB.BO; Bloomberg: PNB IN Asset Quality Continues To Disappoint Punjab National Bank s (PNB) annualised loan slippage

More information

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536 4QFY17 Result Update La Opala RG 11 May 217 Reuters: LAOP.BO; Bloomberg: LOG IN Revenues Soar, But Margins Take A Hit La Opala RG (LORL) reported revenues of Rs761mn for 4QFY17, up 41% YoY. The stellar

More information

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1% 4QFY18 Result Update Institutional Equities ITC 17 May 2018 Reuters: ITC.NS; Bloomberg: ITC IN Tracking Expectations ITC s growth in 4QFY18 was modest and in line with expectations. On the revenue side,

More information

Gillette India. Institutional Equities. 1QFY18 Result Update

Gillette India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities Gillette India 14 November 2017 Reuters: GILE.NS; Bloomberg: GILL IN Robust Growth In Operating Margin Gillette India s or GIL s overall top-line performance

More information

Swiss Glascoat Equipments

Swiss Glascoat Equipments Management Meet Update Institutional Equities Swiss Glascoat Equipments 28 December 17 Reuters: SWGE.BO; Bloomberg: SWGE IN We had a meeting with the management of Swiss Glascoat Equipments (SGEL) recently

More information

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY 3QFY17 Result Update Institutional Equities Manappuram Finance 9 February 2017 Reuters: MNFL.BO; Bloomberg: MGFL IN Profitability Beats Expectations Amid Some Spike In Loan Delinquency Strong Profit &

More information

Indian Oil Corporation

Indian Oil Corporation 3QFY18 Result Update Institutional Equities Indian Oil Corporation 1 February 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Earnings Outperformance On Account Of Inventory Gains Indian Oil Corporation (IOCL)

More information

Institutional Equities

Institutional Equities 4QFY18 Result Update Institutional Equities Atul Auto 30 May 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Mar Profitability Atul Auto s (AAL) 4QFY18 earnings missed our expectations on account

More information

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY 3QCY18 Result Update Institutional Equities Sanofi India Reuters: SANO.BO; Bloomberg: SANL IN Robust Performance Sanofi India s revenues in 3QCY18 stood at Rs7,438mn which were above our/consensus estimate

More information

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution 2QFY19 Result Update Power Mech Projects 21 November 218 Reuters: POMP.BO; Bloomberg: POWM IN Strong Order Book Drives Robust Execution Power Mech Projects (PMPL) posted 2QFY19 consolidated revenues of

More information

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1% Management Meet Update Bata India Reuters: BATA.BO; Bloomberg: BATA IN On Right Track We had a meeting recently with Mr. R. K. Gupta, Chief Financial Officer (CFO) of Bata India (BIL) to understand recent

More information

La Opala RG. Institutional Equities. 1QFY18 Result Update

La Opala RG. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update La Opala RG 31 August 2017 Reuters: LAOP.BO; Bloomberg: LOG IN Flattish YoY Performance La Opala RG (LORL) reported revenues of Rs475mn for 1QFY18, up 0.6% YoY, but significantly below

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Dalmia Bharat Enterprises 1 November 218 Reuters: DALA.BO; Bloomberg: DBEL IN Performance In Line; Stock Under Review Post Odisha Cement Amalgamation Dalmia Bharat Enterprises (DBEL) reported

More information

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017 Management Meet Update Atul Auto 23 August 2017 Reuters: ATUL.BO; Bloomberg: ATUL IN We had a meeting with the management of Atul Auto (AAL) recently to gauge its performance in the aftermath of a relatively

More information

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN 2QFY19 Result Update Maruti Suzuki India 26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN Better-than-expected Margins; Retain Buy Maruti Suzuki India (MSIL) s 2QFY19 earnings were 18% above our estimate

More information

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy 1QFY16 Result Update Institutional Equities JBF Industries 12 August 215 Reuters: JBFI.BO; Bloomberg: JBF IN Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy Following the decline in crude

More information

Sun Pharmaceutical Industries

Sun Pharmaceutical Industries Event Update Institutional Equities Sun Pharmaceutical Industries Reuters: SUN.BO; Bloomberg: SUNP IN Surprise Audit Of Halol Unit By USFDA - Outcome Is Key As per a report in the Business Standard newspaper

More information

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21% Conference-call Update Institutional Equities V-Guard Industries 7 November 214 Reuters: VGUA.NS; Bloomberg: VGRD IN We hosted the conference-call of V-Guard Industries (VIL) on 5 November 214 to discuss

More information

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL 3QFY18 Result Update Institutional Equities Thermax 8 February 2018 Reuters: THMX.BO; Bloomberg: TMX IN Healthy Execution, But Margins Disappoint Thermax posted healthy execution in 3QFY18 with standalone

More information

Institutional Equities

Institutional Equities 3QFY18 Result Update Institutional Equities Atul Auto 15 February 2018 Reuters: ATUL.BO; Bloomberg: ATUL IN Higher Expenses Drag Profitability Atul Auto s (AAL) 3QFY18 earnings missed our expectations

More information

Indian Oil Corporation

Indian Oil Corporation 4QFY18 Result Update Institutional Equities Indian Oil Corporation 24 May 2018 Reuters: IOC.BO; Bloomberg: IOCL IN Subdued Earnings Because Of Lower GRM and Higher Expenses Indian Oil Corporation (IOCL)

More information

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016 Management Meet Update Institutional Equities Voltas Reuters: VOLT.BO; Bloomberg: VOLT IN We had a meeting with the management of Voltas recently to get the latest business update. While the management

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Aurobindo Pharma 13 August 2018 Reuters: ARBP.NS; Bloomberg: ARBP IN One-offs Impact Margin Aurobindo Pharma (APL) reported 1QFY19 revenues of Rs42,503mn which

More information

Institutional Equities

Institutional Equities 2QFY13 Result Update Institutional Equities Reliance Infrastructure 7 November 2012 Reuters: RELIN.BO; Bloomberg: RELI IN Project Execution On Track Reliance Infrastructure reported revenue decline of

More information

State Bank of India. Institutional Equities. 1QFY18 Result Update

State Bank of India. Institutional Equities. 1QFY18 Result Update 1QFY18 Result Update Institutional Equities State Bank of India 14 August 2017 Reuters: SBI.BO; Bloomberg: SBIN IN Merger With Associate Banks Accentuates The Pain State Bank of India s (SBI) annualised

More information

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19% 1QCY18 Result Update Institutional Equities Nestle India 11 May 218 Reuters: NEST.BO; Bloomberg: NEST IN Resurgence Continues Nestle India (NEST) reported strong overall performance during 1QCY18 driven

More information

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update 4QFY18 Result Update Institutional Equities Hindustan Unilever 15 May 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Reaping Rewards Of Consistency 4QFY18 was the third consecutive quarter wherein Hindustan

More information

Institutional Equities

Institutional Equities 3QCY18 Result Update Institutional Equities Cognizant Technology Solutions 31 October 2018 Bloomberg: CTSH US A Rather Tame End To What Should Have Been A Great Year Post its 3QCY2018 results (which was

More information

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE 1QFY19 Result Update Voltas 13 August 218 Reuters: VOLT.BO; Bloomberg: VOLT IN EMPS Shines, UCP Proves Its Mettle Again Voltas reported consolidated revenues of Rs21.5bn for 1QFY19, up 11% YoY and 5%/6%

More information

EBITDA 5,076 3, , EBITDA

EBITDA 5,076 3, , EBITDA Result Update Ambuja Cements 21 February 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Healthy Volume Growth, Operating Costs Under Control Ambuja Cements (ACEM) reported a good set of numbers for owing to

More information

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE 4QFY18 Result Update Institutional Equities Dabur India 3 May 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Growth Volatility Is Still Fairly High Dabur India s (DABUR) consolidated top-line performance in

More information

Tech Mahindra. Institutional Equities. 2QFY19 Result Update ACCUMULATE

Tech Mahindra. Institutional Equities. 2QFY19 Result Update ACCUMULATE Result Update Institutional Equities Tech Mahindra 31 October 18 Reuters: TEML.BO; Bloomberg: TECHM IN Margins Continue To Surprise; Revenues And DSOs Disappoint The performance of Tech Mahindra (TML)

More information

FY11 FY12 FY13E FY14E

FY11 FY12 FY13E FY14E Plant Visit Note Institutional Equities JBF Industries 10 October 2012 Reuters: JBFI.BO; Bloomberg: JBF IN We paid a visit to the plants of JBF Industries at Silvassa, Dadra & Nagar Haveli and also at

More information

Institutional Equities

Institutional Equities 1QFY18 Result Update Institutional Equities Cipla 14 August 2017 Reuters: CIPL.NS; Bloomberg: CIPLA IN Gross Margin Improvement Is A Positive Surprise Cipla s revenues in 1QFY18 stood at Rs35,251mn, showing

More information

Persistent Systems. Institutional Equities. 4QFY18 Result Update ACCUMULATE. Double Digit Growth With Better Margins Likely In FY19

Persistent Systems. Institutional Equities. 4QFY18 Result Update ACCUMULATE. Double Digit Growth With Better Margins Likely In FY19 Result Update Institutional Equities Persistent Systems Reuters: PERS.BO; Bloomberg: PSYS IN Double Digit Growth With Better Margins Likely In FY19 Persistent Systems (PSL) revenues were in line with our

More information

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin Management Meet Update Institutional Equities KEC International Reuters: KECL.BO; Bloomberg: KECI IN On Course Towards Recovery In Operating Margin We had a meeting with the management of KEC International

More information

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY Conference Update Institutional Equities Mold-Tek Packaging 20 August 2018 Reuters: MOLT.BO; Bloomberg: MTEP IN Promising Growth Outlook We recently interacted with the management of Mold-Tek Packaging

More information

Punjab National Bank

Punjab National Bank 4QFY18 Result Update Institutional Equities Punjab National Bank 16 May 2018 Reuters: PNB.BO; Bloomberg: PNB IN Prompt Corrective Action Looms Punjab National Bank (PNB) reported its 4QFY18 results with

More information

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY Event Update Institutional Equities NESCO 27 August 2018 Reuters: NSEN.NS; Bloomberg: NSE IN Revenues From Bombay Exhibition Centre May Take A Hit This event update relates to an application made on 14

More information

Institutional Equities

Institutional Equities 2QCY18 Result Update Institutional Equities Cognizant Technology Solutions 3 August 2018 Bloomberg: CTSH US No Upward Revision To Guidance As It Picks Its Battles Despite being in one of the best demand

More information

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Hindustan Unilever 17 July 218 Reuters: HLL.BO; Bloomberg: HUVR IN Breakout Growth Hindustan Unilever (HUVR) has delivered strong volume led top-line growth

More information

Wipro. Institutional Equities. 4QFY18 Result Update ACCUMULATE. FY19 Likely To Be Yet Another Year Of Growth Underperformance

Wipro. Institutional Equities. 4QFY18 Result Update ACCUMULATE. FY19 Likely To Be Yet Another Year Of Growth Underperformance 4QFY18 Result Update Institutional Equities Wipro 26 April 2018 Reuters: WIPR.BO; Bloomberg: WPRO IN FY19 Likely To Be Yet Another Year Of Growth Underperformance Wipro s 4QFY18 IT services revenues grew

More information

Punjab National Bank

Punjab National Bank Company Update Punjab National Bank 19 September 2018 Reuters: PNB.BO; Bloomberg: PNB IN Concerns Remain; Assign Accumulate We take Punjab National Bank (PNB) out from Under Review and assign an Accumulate

More information

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018 4QFY18 Result Update Institutional Equities South Indian Bank 15 May 2018 Reuters: SIBK.BO; Bloomberg: SIB IN Asset Quality Pain To Ease Hereafter South Indian Bank (SBL) reported 4QFY18 results with the

More information

Institutional Equities

Institutional Equities 1QFY19 Result Update Institutional Equities Dr. Reddy s Laboratories 27 July 2018 Reuters: REDY.BO; Bloomberg: DRRD IN Drug Pipeline In Place, But Regulatory Hurdles Testing Patience Dr. Reddy s Laboratories

More information

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA 1QFY19 Result Update The Ramco Cements 3 August 218 Reuters: TRCE.BO; Bloomberg: TRCL IN Challenging Business Environment Aptly Handled The Ramco Cements (TRCL) reported a stable operating performance

More information

EBITDA 6,223 6,511 (4.4) 5, EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA Result Update Institutional Equities Ambuja Cements 26 July 218 Reuters: ABUJ.BO; Bloomberg: ACEM IN Performance Beats Expectations, Sustainability Is Key Challenge Ambuja Cements (ACEM) reported steady

More information

KEC International. Institutional Equities. Management Meet Update. Healthy Order Inflow Traction Expected To Continue BUY

KEC International. Institutional Equities. Management Meet Update. Healthy Order Inflow Traction Expected To Continue BUY Management Meet Update Institutional Equities KEC International Reuters: KECL.BO; Bloomberg: KECI IN Healthy Order Inflow Traction Expected To Continue We had a meeting with the management of KEC International

More information

Dabur India. Institutional Equities. 1QFY19 Result Update

Dabur India. Institutional Equities. 1QFY19 Result Update 1QFY19 Result Update Institutional Equities Dabur India 2 August 2018 Reuters: DABU.NS; Bloomberg: DABUR IN Consistency Is Key To The Game Dabur India s (DABUR) operating performance in 1QFY19 was better

More information

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN Management Meet Update Institutional Equities Eicher Motors 17 July 2018 Reuters: EICH.NS; Bloomberg: EIM IN We had a meeting with the management of Eicher Motors (EML) recently. Following are the key

More information

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA Result Update The India Cements 12 November 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Lackluster Performance The India Cements (ICEM) reported a listless operating performance in because of the sustained

More information

TD Power Systems. Institutional Equities. Company Update BUY

TD Power Systems. Institutional Equities. Company Update BUY Company Update Institutional Equities TD Power Systems 1 September 215 Reuters: TDPS.BO; Bloomberg: TDPS IN On The Cusp Of A Turnaround; Reiterate Buy We believe TD Power Systems (TDPS) is on the cusp

More information

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL 3QFY19 Result Update TVS Motor Company 23 January 2019 Reuters: TVSM.BO; Bloomberg: TVSL IN Better-Than-Expected Margins TVS Motor Company s 3QFY19 performance was above our expectations as it reported

More information

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises Result Update Institutional Equities Dalmia Bharat Enterprises Reuters: DALA.BO; Bloomberg: DBEL IN 14 August 218 Listless Performance, But Valuation Premium Continues Dalmia Bharat Enterprises (DBEL)

More information

Apar Industries. Institutional Equities. Management Meet Update. In Turnaround Mode; Retain Buy BUY

Apar Industries. Institutional Equities. Management Meet Update. In Turnaround Mode; Retain Buy BUY Management Meet Update Institutional Equities Apar Industries Reuters: APAR.BO; Bloomberg: APR IN In Turnaround Mode; Retain Buy We had a meeting with the management of Apar Industries (Apar) recently

More information

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update

Hindustan Unilever. Institutional Equities. 2QFY19 Result Update 2QFY19 Result Update Institutional Equities Hindustan Unilever 15 October 2018 Reuters: HLL.BO; Bloomberg: HUVR IN Best Proxy In A VUCA World Hindustan Unilever s (HUVR) overall performance in 2QFY19 was

More information

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE Event Update Institutional Equities ACC 19 December 218 Reuters: ACC.BO; Bloomberg: ACC IN Capacity Expansion To Consolidate Presence In Central India ACC has announced 5.9mt capacity expansion by adding

More information

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY Result Update Mangalam Cement 16 February 2018 Reuters: MGLC.BO; Bloomberg: MGC IN Higher Operating costs Hurt Performance Mangalam Cement (MGC) reported a weak performance for on account of higher operating

More information

The Ramco Cements. Institutional Equities. Event Update BUY

The Ramco Cements. Institutional Equities. Event Update BUY Event Update The Ramco Cements 21 December 2018 Reuters: TRCE.BO; Bloomberg: TRCL IN Capacity Expansion To Boost Its Presence In Andhra & Telangana The Ramco Cements (TRCL) has announced 3.15mt cement

More information

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY. 3QFY18 Result Update Institutional Equities IFB Industries Reuters: IFBI.BO; Bloomberg: IFBI IN Healthy Revenues, Strong Gross Margin; Retain Buy IFB Industries (IFB) posted a healthy 17% YoY rise in net

More information

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018 4QFY18 Result Update Institutional Equities PNB Housing Finance 4 May 2018 Reuters: PNBH.NS; Bloomberg: PNBHOUSI IN Continued Display of Embedded Scalability PNB Housing Finance (PNBHF) reported 4QFY18

More information

Arvind. Institutional Equities. Event Update BUY

Arvind. Institutional Equities. Event Update BUY Event Update Institutional Equities Arvind 3 July 2015 Reuters: ARVN.BO; Bloomberg: ARVND IN Arvind Lifestyle Inks Licencing Pact with US-based Aeropostale Arvind s subsidiary, Arvind Lifestyle Brands

More information

Natco Pharma. Institutional Equities. 3QFY15 Result Update

Natco Pharma. Institutional Equities. 3QFY15 Result Update 3QFY15 Result Update Institutional Equities Natco Pharma 12 February 2015 Reuters: NATP.BO; Bloomberg: NTCPH IN Weak Performance Natco Pharma s (NPL) 3QFY15 performance was below expectations with reported

More information

Huhtamaki PPL. Institutional Equities. Management Meet Update NOT RATED. CMP: Rs186 Sector: Packaging. 16 September 2014

Huhtamaki PPL. Institutional Equities. Management Meet Update NOT RATED. CMP: Rs186 Sector: Packaging. 16 September 2014 Management Meet Update Institutional Equities Reuters: HUHT.BO; Bloomberg: HPPL IN We met the management of (formerly Paper Products). After announcement of the acquisition of Positive Packaging by two

More information

Bharat Financial Inclusion

Bharat Financial Inclusion 3QFY18 Result Update Bharat Financial Inclusion Reuters: BHAF.NS; Bloomberg: BHAFIN IN 31 January 2018 Customer Acquisition Accelerates Meaningfully Bharat Financial Inclusion (BFIL) reported its 3QFY18

More information

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY 1QFY19 Result Update Sequent Scientific 13 August 2018 Reuters: SEQU.BO; Bloomberg: SEQ IN Regulatory Changes And Adverse Forex Movement Dampens Momentum Sequent Scientific or SSL s revenues at Rs2,369mn

More information

Institutional Equities

Institutional Equities 10 April 2019 4QFY19 Result Preview Gains Versus El Nino Headwind Holds The Key; Retain Buy We remain positive on and retain our Buy call on it based on 24% upside to our blended target price of Rs1,134

More information

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY

Bata India. Institutional Equities. Management Meet Update. Likely Getting Into A Virtuous Cycle BUY Management Meet Update Institutional Equities Bata India 25 June 2018 Reuters: BATA.BO; Bloomberg: BATA IN Likely Getting Into A Virtuous Cycle We had a meeting with the management of Bata India (BIL)

More information

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN 4QFY18 Result Update Institutional Equities Karnataka Bank 17 May 2018 Reuters: KBNK.NS; Bloomberg: KBL IN Plucky Bank And Low Hanging Fruit Karnataka Bank (KBL) reported 4QFY18 results with the key strategic

More information

Infosys. Institutional Equities. 2QFY19 Result Update ACCUMULATE

Infosys. Institutional Equities. 2QFY19 Result Update ACCUMULATE Result Update Infosys 17 October 218 Reuters: INFY.BO; Bloomberg: INFO IN Strongest TCV Ever, But At A Cost; We Like The Growth Focus Shrugging itself off from a turbulent 217, Infosys recorded best ever

More information

Tata Consultancy Services (TCS)

Tata Consultancy Services (TCS) Jan-16 Jun-16 Nov-16 Apr-17 Sep-17 Feb-18 Jul-18 Dec-18 3QFY2019 Result Update IT January 11, 2019 Tata Consultancy Services (TCS) Performance highlights (` cr) 3QFY19 2QFY19 % chg (QoQ) 3QFY18 % chg (yoy)

More information

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018 3QFY18 Result Update Institutional Equities Manappuram Finance 9 February 2018 Reuters: MNFL.BO; Bloomberg: MGFL IN The Glitter Is Back In Gold Loans Manappuram Finance (MFL) reported its 3QFY18 results

More information